Epicore Bionetworks (EPCBF) 0.2570 $EPCBF
Epicore BioNetworks Inc. Reports Record Results for Quarter Two Fiscal Year 2014
GlobeNewswire - Tue Feb 18, 3:30PM CST
Epicore BioNetworks Inc. (TSX-V:EBN) revenue for Q2 at $1.7 million was 25% higher than last year's Q2 and set a new company Q2 record. This record follows a record Q1 and a record fiscal 2013 Q4. Sales were broad based and not regionally limited as producers worldwide try to capitalize on record high shrimp prices. Early Mortality Syndrome (EMS) in Asia has reduced the worldwide supply of shrimp, which in turn has pushed shrimp prices to record levels. High shrimp prices have increased the demand for Epicore's productivity enhancing products.
Epicore Appoints New Chairman and Grants Stock Options
GlobeNewswire - Mon Feb 10, 3:52PM CST
The Board of Directors of Epicore BioNetworks Inc. (TSX-V:EBN) reports that its Chairman of the Board of Directors, Mr. Philip A.D. Secretan, is stepping down but will continue to serve the Company as a non-executive director. Mr. Secretan has been an enthusiastic supporter of Epicore and served the board well in his seven years as Chairman. During his tenure, the Company saw sales increase 2.8 times, was profitable in every quarter of operation and has grown to become a significant supplier to the world aquaculture industry. Mr. Secretan leaves chairman's position with the Company on solid financial footings, ready to grow its business to the next level and to reward the support of its shareholders.
Epicore BioNetworks Inc. Normal Course Issuer Bid
GlobeNewswire - Fri Jan 10, 9:43AM CST
Epicore BioNetworks Inc. ("Epicore") (TSX-V:EBN) announced today that in connection with its Normal Course Issuer Bid conducted through the facilities of the TSX Venture Exchange that the Member conducting the Normal Course Issuer Bid has been changed from Macquarie Private Wealth to Richardson GMP Limited due to the acquisition of the former by the latter.
Epicore BioNetworks Inc. Stock Option Exercise
GlobeNewswire - Mon Dec 02, 3:35PM CST
Epicore (TSX-V:EBN) announces that a non-executive member of the Board of Directors, Fred N. Boulos, exercised 100,000 of his allotted common stock options. The options were exercised at the price granted, which was Cdn. $0.10 per share. With this transaction Epicore common shares outstanding increased 0.4% to 25,385,396. Mr. Boulos's ownership of Epicore shares becomes 564,000, which is 2.2% of shares outstanding.
Epicore BioNetworks Inc. Reports Record Results for Quarter One Fiscal Year 2014
GlobeNewswire - Tue Nov 05, 3:35PM CST
Epicore BioNetworks Inc. (TSX-V:EBN) revenue for Q1 at $1.6 million was 48% higher than last year's Q1 and set a new company Q1 record. This record follows a record fiscal 2013 Q4. Sales were broad based and not regionally limited as producers worldwide try to capitalize on record high shrimp prices. Early Mortality Syndrome (EMS) in Asia has caused farm closures that hurt Epicore sales throughout 2013 and have reduced the worldwide supply of shrimp, which in turn has pushed up shrimp prices. Demand for shrimp has dropped slightly because of the high prices. Epicore products help shrimp operations enhance their productivity so are in high demand when shrimp prices are high.
Epicore BioNetworks Inc. Reports Results for Fiscal Year 2013
GlobeNewswire - Thu Oct 10, 3:35PM CDT
Epicore (TSX-V:EBN) was able to maintain its fiscal 2013 sales revenues at fiscal 2012 level despite a difficult year for the shrimp aquaculture industry. Quarter four sales outperformed the first three months of the year and set a Company record. Fiscal 2013 gross profit increased 3% due to sales mix. Cash generation was strong in the year (19% above fiscal 2012) and shareholder equity increased 12% to $5.4 million. Fiscal 2013 saw a major investment in manufacturing resources, which will have a favorable effect on future operations but contributed to a 27% drop in fiscal 2013 net income.
Epicore BioNetworks Inc. Announces Normal Course Issuer Bid
PR Newswire Europe - Mon Aug 26, 3:30PM CDT
CALGARY, Alberta, August 26, 2013 /PRNewswire/ --
Epicore BioNetworks Inc. Announces Personnel Changes
PR Newswire Europe - Fri Aug 09, 4:27PM CDT
CALGARY, Alberta, August 9, 2013 /PRNewswire/ --
Epicore BioNetworks Inc. Quarter Three Fiscal Year 2013
PR Newswire Europe - Fri May 24, 3:36PM CDT
CALGARY, Alberta, May 24, 2013 /PRNewswire/ --
Epicore BioNetworks Inc. Quarter Two Fiscal Year 2013
PR Newswire Europe - Thu Feb 28, 3:40PM CST
CALGARY, February 28, 2013 /PRNewswire/ --
Epicore BioNetworks Inc. Announces Stock Option Grants
PR Newswire Europe - Fri Feb 08, 3:32PM CST
CALGARY, Alberta, February 8, 2013 /PRNewswire/ --
Epicore BioNetworks Inc. Announces New Board Director and Stock Option Exercise
PR Newswire Europe - Fri Jan 18, 6:44PM CST
The Board of Directors of Epicore BioNetworks Inc. is pleased to announce a new director has joined the board, effective January 16, 2013. The Board welcomes Mr. Alan Savage of Vancouver, British Columbia, Canada.
Epicore BioNetworks Inc. Reports Record Results for Quarter Two Fiscal Year 2014
GlobeNewswire - Tue Feb 18, 3:30PM CST
Epicore BioNetworks Inc. (TSX-V:EBN) revenue for Q2 at $1.7 million was 25% higher than last year's Q2 and set a new company Q2 record. This record follows a record Q1 and a record fiscal 2013 Q4. Sales were broad based and not regionally limited as producers worldwide try to capitalize on record high shrimp prices. Early Mortality Syndrome (EMS) in Asia has reduced the worldwide supply of shrimp, which in turn has pushed shrimp prices to record levels. High shrimp prices have increased the demand for Epicore's productivity enhancing products.
Epicore Appoints New Chairman and Grants Stock Options
GlobeNewswire - Mon Feb 10, 3:52PM CST
The Board of Directors of Epicore BioNetworks Inc. (TSX-V:EBN) reports that its Chairman of the Board of Directors, Mr. Philip A.D. Secretan, is stepping down but will continue to serve the Company as a non-executive director. Mr. Secretan has been an enthusiastic supporter of Epicore and served the board well in his seven years as Chairman. During his tenure, the Company saw sales increase 2.8 times, was profitable in every quarter of operation and has grown to become a significant supplier to the world aquaculture industry. Mr. Secretan leaves chairman's position with the Company on solid financial footings, ready to grow its business to the next level and to reward the support of its shareholders.
Epicore BioNetworks Inc. Normal Course Issuer Bid
GlobeNewswire - Fri Jan 10, 9:43AM CST
Epicore BioNetworks Inc. ("Epicore") (TSX-V:EBN) announced today that in connection with its Normal Course Issuer Bid conducted through the facilities of the TSX Venture Exchange that the Member conducting the Normal Course Issuer Bid has been changed from Macquarie Private Wealth to Richardson GMP Limited due to the acquisition of the former by the latter.
Epicore BioNetworks Inc. Stock Option Exercise
GlobeNewswire - Mon Dec 02, 3:35PM CST
Epicore (TSX-V:EBN) announces that a non-executive member of the Board of Directors, Fred N. Boulos, exercised 100,000 of his allotted common stock options. The options were exercised at the price granted, which was Cdn. $0.10 per share. With this transaction Epicore common shares outstanding increased 0.4% to 25,385,396. Mr. Boulos's ownership of Epicore shares becomes 564,000, which is 2.2% of shares outstanding.
Epicore BioNetworks Inc. Reports Record Results for Quarter One Fiscal Year 2014
GlobeNewswire - Tue Nov 05, 3:35PM CST
Epicore BioNetworks Inc. (TSX-V:EBN) revenue for Q1 at $1.6 million was 48% higher than last year's Q1 and set a new company Q1 record. This record follows a record fiscal 2013 Q4. Sales were broad based and not regionally limited as producers worldwide try to capitalize on record high shrimp prices. Early Mortality Syndrome (EMS) in Asia has caused farm closures that hurt Epicore sales throughout 2013 and have reduced the worldwide supply of shrimp, which in turn has pushed up shrimp prices. Demand for shrimp has dropped slightly because of the high prices. Epicore products help shrimp operations enhance their productivity so are in high demand when shrimp prices are high.
Epicore BioNetworks Inc. Reports Results for Fiscal Year 2013
GlobeNewswire - Thu Oct 10, 3:35PM CDT
Epicore (TSX-V:EBN) was able to maintain its fiscal 2013 sales revenues at fiscal 2012 level despite a difficult year for the shrimp aquaculture industry. Quarter four sales outperformed the first three months of the year and set a Company record. Fiscal 2013 gross profit increased 3% due to sales mix. Cash generation was strong in the year (19% above fiscal 2012) and shareholder equity increased 12% to $5.4 million. Fiscal 2013 saw a major investment in manufacturing resources, which will have a favorable effect on future operations but contributed to a 27% drop in fiscal 2013 net income.
Epicore BioNetworks Inc. Announces Normal Course Issuer Bid
PR Newswire Europe - Mon Aug 26, 3:30PM CDT
CALGARY, Alberta, August 26, 2013 /PRNewswire/ --
Epicore BioNetworks Inc. Announces Personnel Changes
PR Newswire Europe - Fri Aug 09, 4:27PM CDT
CALGARY, Alberta, August 9, 2013 /PRNewswire/ --
Epicore BioNetworks Inc. Quarter Three Fiscal Year 2013
PR Newswire Europe - Fri May 24, 3:36PM CDT
CALGARY, Alberta, May 24, 2013 /PRNewswire/ --
Epicore BioNetworks Inc. Quarter Two Fiscal Year 2013
PR Newswire Europe - Thu Feb 28, 3:40PM CST
CALGARY, February 28, 2013 /PRNewswire/ --
Epicore BioNetworks Inc. Announces Stock Option Grants
PR Newswire Europe - Fri Feb 08, 3:32PM CST
CALGARY, Alberta, February 8, 2013 /PRNewswire/ --
Epicore BioNetworks Inc. Announces New Board Director and Stock Option Exercise
PR Newswire Europe - Fri Jan 18, 6:44PM CST
The Board of Directors of Epicore BioNetworks Inc. is pleased to announce a new director has joined the board, effective January 16, 2013. The Board welcomes Mr. Alan Savage of Vancouver, British Columbia, Canada.
